171 related articles for article (PubMed ID: 15214798)
1. Inhibition of cytokine production by hymenialdisine derivatives.
Sharma V; Lansdell TA; Jin G; Tepe JJ
J Med Chem; 2004 Jul; 47(14):3700-3. PubMed ID: 15214798
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.
Sharma V; Tepe JJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4319-21. PubMed ID: 15261294
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).
Anderson DR; Meyers MJ; Vernier WF; Mahoney MW; Kurumbail RG; Caspers N; Poda GI; Schindler JF; Reitz DB; Mourey RJ
J Med Chem; 2007 May; 50(11):2647-54. PubMed ID: 17480064
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and target identification of hymenialdisine analogs.
Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS
Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286
[TBL] [Abstract][Full Text] [Related]
6. A new glycociamidine ring precursor: syntheses of (Z)-hymenialdisine, (Z)-2-debromohymenialdisine, and (+/-)-endo-2-debromohymenialdisine.
Papeo G; Posteri H; Borghi D; Varasi M
Org Lett; 2005 Dec; 7(25):5641-4. PubMed ID: 16321011
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis and structural confirmation of chlorodysinosin A.
Hanessian S; Del Valle JR; Xue Y; Blomberg N
J Am Chem Soc; 2006 Aug; 128(32):10491-5. PubMed ID: 16895415
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.
Hynes J; Dyckman AJ; Lin S; Wrobleski ST; Wu H; Gillooly KM; Kanner SB; Lonial H; Loo D; McIntyre KW; Pitt S; Shen DR; Shuster DJ; Yang X; Zhang R; Behnia K; Zhang H; Marathe PH; Doweyko AM; Tokarski JS; Sack JS; Pokross M; Kiefer SE; Newitt JA; Barrish JC; Dodd J; Schieven GL; Leftheris K
J Med Chem; 2008 Jan; 51(1):4-16. PubMed ID: 18072718
[TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.
Xie J; Tian J; Su L; Huang M; Zhu X; Ye F; Wan Y
Bioorg Med Chem Lett; 2011 Jul; 21(14):4306-9. PubMed ID: 21696953
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors.
Bharate SB; Mahajan TR; Gole YR; Nambiar M; Matan TT; Kulkarni-Almeida A; Balachandran S; Junjappa H; Balakrishnan A; Vishwakarma RA
Bioorg Med Chem; 2008 Aug; 16(15):7167-76. PubMed ID: 18625560
[TBL] [Abstract][Full Text] [Related]
11. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors.
Kim HM; Ryu DK; Choi Y; Park BW; Lee K; Han SB; Lee CW; Kang MR; Kang JS; Boovanahalli SK; Park SK; Han JW; Chun TG; Lee HY; Nam KY; Choi EH; Han G
J Med Chem; 2007 May; 50(11):2737-41. PubMed ID: 17477518
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents.
Radwan MA; Ragab EA; Sabry NM; El-Shenawy SM
Bioorg Med Chem; 2007 Jun; 15(11):3832-41. PubMed ID: 17395469
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in the study of pharmacological activities and solid-phase synthesis of indoles and their analogues].
Yang TM; Liu G
Yao Xue Xue Bao; 2006 Aug; 41(8):694-701. PubMed ID: 17039771
[No Abstract] [Full Text] [Related]
15. Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors.
Saleem RS; Lansdell TA; Tepe JJ
Bioorg Med Chem; 2012 Feb; 20(4):1475-81. PubMed ID: 22285028
[TBL] [Abstract][Full Text] [Related]
16. Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors.
Nguyen TN; Tepe JJ
Curr Med Chem; 2009; 16(24):3122-43. PubMed ID: 19689287
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-inflammation evaluation of new C60 fulleropyrrolidines bearing biologically active xanthine.
Huang ST; Liao JS; Fang HW; Lin CM
Bioorg Med Chem Lett; 2008 Jan; 18(1):99-103. PubMed ID: 18023183
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues.
Parmentier JG; Portevin B; Golsteyn RM; Pierré A; Hickman J; Gloanec P; De Nanteuil G
Bioorg Med Chem Lett; 2009 Feb; 19(3):841-4. PubMed ID: 19111462
[TBL] [Abstract][Full Text] [Related]
19. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
Yamamoto S; Sugahara S; Naito R; Ichikawa A; Ikeda K; Yamada T; Shimizu Y
Eur J Pharmacol; 2006 Jul; 541(1-2):106-14. PubMed ID: 16780833
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha.
Hilmy KM
Arch Pharm (Weinheim); 2004 Jan; 337(1):15-9. PubMed ID: 14760623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]